BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1526557)

  • 1. [Substance abuse among mental patients].
    Knobler H; Katz G; Srur N; Maizel S; Margolin Y; Lerner Y
    Harefuah; 1992 Jun; 122(11):692-4, 752. PubMed ID: 1526557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance abuse in hospitalized psychiatric patients.
    Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
    Isr Med Assoc J; 2008 Oct; 10(10):672-5. PubMed ID: 19009943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of psychiatric disorders in Edmonton. Drug abuse and dependence.
    Russell JM; Newman SC; Bland RC
    Acta Psychiatr Scand Suppl; 1994; 376():54-62. PubMed ID: 8178686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric referrals associated with substance use disorders: prevalence and gender differences. European Consultation-Liaison Workgroup.
    Alaja R; Seppä K; Sillanaukee P; Tienari P; Huyse FJ; Herzog T; Malt UF; Lobo A
    Alcohol Clin Exp Res; 1997 Jun; 21(4):620-6. PubMed ID: 9194914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug abuse among patients requiring psychiatric hospitalization].
    Katz G; Shufman E; Knobler HY; Joffe M; Bar-Hamburger R; Durst R
    Harefuah; 2000 Jun; 138(12):1015-8, 1088. PubMed ID: 10979421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women.
    Kendler KS; Prescott CA; Myers J; Neale MC
    Arch Gen Psychiatry; 2003 Sep; 60(9):929-37. PubMed ID: 12963675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon.
    Karam EG; Yabroudi PF; Melhem NM
    Compr Psychiatry; 2002; 43(6):463-8. PubMed ID: 12439834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study of substance dependence patients combined with other psychiatric disorders].
    Kuwata T; Suwaki H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Oct; 33(5):574-86. PubMed ID: 9844377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative and positive childhood experiences across developmental periods in psychiatric patients with different diagnoses - an explorative study.
    Saleptsi E; Bichescu D; Rockstroh B; Neuner F; Schauer M; Studer K; Hoffmann K; Elbert T
    BMC Psychiatry; 2004 Nov; 4():40. PubMed ID: 15566566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoactive substance use among patients admitted to an acute psychiatric ward: laboratory findings and associations with clinical characteristics.
    Mordal J; Holm B; Gossop M; Romøren M; Mørland J; Bramness J
    Nord J Psychiatry; 2011 Jun; 65(3):208-15. PubMed ID: 21047195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug abuse among patients in the somatic hospital system].
    Hansen SS
    Ugeskr Laeger; 1999 Nov; 161(46):6344-50. PubMed ID: 10611833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients.
    Nylander L; Holmqvist M; Gustafson L; Gillberg C
    Nord J Psychiatry; 2009; 63(1):64-71. PubMed ID: 18991159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.